System with embedded drug release and nanoparticle degradation sensor showing efficient rifampicin delivery into macrophages

详细信息    查看全文

• 作者：Jiř&iacute ; Trousil ; MSc^a ; Sergey K. Filippov ; PhD^a ; Martin Hrubý ; PhD^a ; ^{mhruby@centrum.cz} ; Tomá ; &scaron ; Mazel ; PhD^b ; Zdeňka Syrová ; PhD^b ; Du&scaron ; an Cmarko ; PhD^b ; Silvie Svidenská ; MSc^b ; Jana Matějková ; MD^c ; Lubom&iacute ; r Ková ; čik ; PhD^b ; Bedřich Porsch ; PhD^a ; Rafał Konefał ; MSc^a ; Reidar Lund ; PhD^d ; Bo Nyströ ; m^d ; Ivan Ra&scaron ; ka^b ; Petr &Scaron ; těpá ; nek ; PhD^a
• 关键词：Tuberculosis ; Rifampicin ; Nanoparticle ; MPEO-b-PCL ; FRET
• 刊名：Nanomedicine: Nanotechnology, Biology and Medicine
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：13
• 期：1
• 页码：307-315
• 全文大小：1470 K
• 卷排序：13

文摘

We have developed a biodegradable, biocompatible system for the delivery of the antituberculotic antibiotic rifampicin with a built-in drug release and nanoparticle degradation fluorescence sensor. Polymer nanoparticles based on poly(ethylene oxide) monomethyl ether-block-poly(ε-caprolactone) were noncovalently loaded with rifampicin, a combination that, to best of our knowledge, was not previously described in the literature, which showed significant benefits. The nanoparticles contain a Förster resonance energy transfer (FRET) system that allows real-time assessment of drug release not only in vitro, but also in living macrophages where the mycobacteria typically reside as hard-to-kill intracellular parasites. The fluorophore also enables in situ monitoring of the enzymatic nanoparticle degradation in the macrophages. We show that the nanoparticles are efficiently taken up by macrophages, where they are very quickly associated with the lysosomal compartment. After drug release, the nanoparticles in the cmacrophages are enzymatically degraded, with half-life 88 ± 11 min.